In the present study, we explored the association between specific biomarkers of Alzheimer’s Disease (AD), amyloid-beta 42 (Aβ42) and Tau with the odds of SCD using data from two ongoing studies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.